The Advisory Board Co. (NASDAQ:ABCO) CEO Robert W. Musslewhite sold 5,500 shares of The Advisory Board stock in a transaction that occurred on Monday, September 12th. The shares were sold at an average price of $43.09, for a total value of $236,995.00. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website.

Shares of The Advisory Board Co. (NASDAQ:ABCO) opened at 42.92 on Tuesday. The stock’s market capitalization is $1.73 billion. The firm’s 50-day moving average is $42.14 and its 200-day moving average is $35.58. The Advisory Board Co. has a 52 week low of $18.87 and a 52 week high of $54.84.

The Advisory Board (NASDAQ:ABCO) last announced its earnings results on Wednesday, July 27th. The company reported $0.47 earnings per share for the quarter, topping the consensus estimate of $0.34 by $0.13. The Advisory Board had a negative net margin of 10.21% and a positive return on equity of 11.59%. The firm had revenue of $198.40 million for the quarter, compared to the consensus estimate of $196.49 million. During the same period in the prior year, the firm earned $0.40 EPS. The firm’s revenue for the quarter was up 7.4% on a year-over-year basis. Analysts forecast that The Advisory Board Co. will post $1.86 earnings per share for the current fiscal year.

Large investors have recently made changes to their positions in the company. BlackRock Inc. increased its stake in shares of The Advisory Board by 16.2% in the second quarter. BlackRock Inc. now owns 3,263 shares of the company’s stock valued at $116,000 after buying an additional 455 shares during the last quarter. Teacher Retirement System of Texas increased its stake in shares of The Advisory Board by 13.8% in the second quarter. Teacher Retirement System of Texas now owns 5,856 shares of the company’s stock valued at $207,000 after buying an additional 708 shares during the last quarter. Princeton Alpha Management LP acquired a new stake in shares of The Advisory Board during the second quarter valued at $236,000. Champlain Investment Partners LLC increased its stake in shares of The Advisory Board by 26.6% in the first quarter. Champlain Investment Partners LLC now owns 6,950 shares of the company’s stock valued at $224,000 after buying an additional 1,460 shares during the last quarter. Finally, Raymond James & Associates increased its stake in shares of The Advisory Board by 0.4% in the second quarter. Raymond James & Associates now owns 7,067 shares of the company’s stock valued at $250,000 after buying an additional 28 shares during the last quarter.

Several analysts have weighed in on the company. Canaccord Genuity reaffirmed a “buy” rating on shares of The Advisory Board in a research report on Sunday, May 29th. Oppenheimer Holdings Inc. set a $45.00 price target on The Advisory Board and gave the stock a “buy” rating in a research report on Thursday, July 28th. Cantor Fitzgerald reissued a “hold” rating on shares of The Advisory Board in a research report on Friday, August 19th. Credit Suisse Group AG reissued a “buy” rating and issued a $50.00 price target on shares of The Advisory Board in a research report on Friday. Finally, Craig Hallum raised The Advisory Board from a “hold” rating to a “buy” rating and set a $47.00 price target on the stock in a research report on Thursday, July 28th. Five research analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has given a strong buy rating to the company. The stock has a consensus rating of “Buy” and a consensus target price of $43.40.

The Advisory Board Company Profile

The Advisory Board Company is a provider of software and solutions to the healthcare and higher education industries. The Company’s healthcare programs address a range of clinical and business issues, including physician alignment and engagement, network management and growth strategy, value-based care and population health, revenue cycle, clinical operations and supply chain.

5 Day Chart for NASDAQ:ABCO

Receive News & Ratings for The Advisory Board Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Advisory Board Co. and related companies with MarketBeat.com's FREE daily email newsletter.